Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Of Esophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT07021066
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Who this might be right for
Gastric AdenocarcinomaAdvanced Pancreatic Ductal AdenocarcinomaEsophageal Adenocarcinoma+2 more
SystImmune Inc. 160
Testing effectiveness (Phase 2)UnknownNCT04159974
What this trial is testing

RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus

Who this might be right for
Esophageal Adenocarcinoma
University of Cologne 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT01142388
What this trial is testing

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Metastatic Esophageal AdenocarcinomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+5 more
National Cancer Institute (NCI) 94
Post-approval studies (Phase 4)UnknownNCT00628784
What this trial is testing

Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer

Who this might be right for
Barrett's Esophagus
Walter Reed Army Medical Center 100
Not applicableStudy completedNCT02513784
What this trial is testing

Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome

Who this might be right for
Esophageal AdenocarcinomaBarrett's EsophagusReflux Esophagitis
Columbia University 20
Not applicableEnded earlyNCT02358863
What this trial is testing

Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Georgetown University 13
Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Testing effectiveness (Phase 2)Ended earlyNCT03528876
What this trial is testing

FOLFIRI Alternate With FOLFOX in Untreated Metastatic Gastric and Esophageal Adenocarcinoma

Who this might be right for
Metastatic Gastro-esophageal Adenocarcinoma
University of Saskatchewan 36
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Early research (Phase 1)Study completedNCT00252889
What this trial is testing

Doxil Topotecan Doublet Cancer Study

Who this might be right for
Small Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more
Christiana Care Health Services 20
Testing effectiveness (Phase 2)Study completedNCT00411151
What this trial is testing

Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaBarrett Esophagus
Johannes Gutenberg University Mainz 52
Testing effectiveness (Phase 2)Study completedNCT00006245
What this trial is testing

Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT05911243
What this trial is testing

Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

Who this might be right for
Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage II Gastric Cancer AJCC v8+9 more
University of Washington 3
Large-scale testing (Phase 3)UnknownNCT00509561
What this trial is testing

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Wales Cancer Trials Unit 259
Testing effectiveness (Phase 2)Study completedNCT01298999
What this trial is testing

Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus

Who this might be right for
Barrett's Esophagus
Columbia University 27
Not applicableLooking for participantsNCT07125248
What this trial is testing

Outcomes of a Single Chest Drain vs Two Drains

Who this might be right for
Pleura; EffusionEsophageal AdenocarcinomaEsophageal Anastomotic Leak
Khyber Teaching Hospital 68
Not applicableLooking for participantsNCT03222635
What this trial is testing

Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma

Who this might be right for
Submucosal Esophageal AdenocarcinomaBarrett EsophagusHigh-risk Mucosal Esophageal Adenocarcinoma
Amsterdam UMC 225
Not applicableStudy completedNCT01961778
What this trial is testing

Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma

Who this might be right for
Barrett's Esophagus
Massachusetts General Hospital 50
Not applicableStudy completedNCT00898495
What this trial is testing

Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery

Who this might be right for
Esophageal Cancer
ECOG-ACRIN Cancer Research Group 118
Not applicableStudy completedNCT01393483
What this trial is testing

Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)

Who this might be right for
Esophageal CancerAdenocarcinoma
Memorial Sloan Kettering Cancer Center 371
Next Page